All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @holistichealthcode on TikTok · 110s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @holistichealthcode's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Good morning you guys. I am taking my fourth dose of DVC and I wanted to come on and give you an
  2. 0:07update. So to quickly bring you up to speed I am trying BPC-157 to treat a shoulder injury
  3. 0:14and it also can be helpful for gut healing. So I started this three days ago, four days ago. This
  4. 0:21is my fourth dose this morning. I was recommended by the pharmacy that I collaborate with to start
  5. 0:2725 units and I found out the hard way that that was a little too much for me. I have a colleague that
  6. 0:32specializes in peptide therapy and he did tell me to back off that dosing but I just wanted to try
  7. 0:40I just wanted to try 25. I should have listened. So about an hour after my first dose I was next
  8. 0:48level anxious like anxious or anxiety that I haven't felt in a really long time if ever. So I was like
  9. 0:56okay this is weird. It has to be the peptide although there's a few other like compounding
  10. 1:00variables which there always is. So I didn't want to completely blame the peptide so I did the same
  11. 1:07dose the following day and it happened again and I was like okay this is just not this isn't right
  12. 1:13so yesterday at my third dose I backed off the 10 units which my colleague said to do in the first
  13. 1:18place and I was completely fine. No anxiety, no anxious thoughts and believe it or not I had no
  14. 1:24shoulder pain already at day three. So my shoulder pain does ebb and flow so I don't want to completely
  15. 1:32say like BBC healed my shoulder in three days after like years of ongoing pain but I did do
  16. 1:39Pilates this morning and that's when it tends to flare especially if we focus on shoulders which
  17. 1:44we did today so I'm going to take my third dose 10 units and I'll keep you posted that's the update.

@holistichealthcode's peptide therapy claims need context

hhc+

TikTok creator

96.0K viewsWatch on TikTok

Quick answer

The creator is using self-administered injectable BPC-157 sourced from a compounding pharmacy to address a chronic shoulder injury, reporting dose-dependent anxiety at higher units that resolved upon dose reduction. BPC-157 has demonstrated tendon and connective tissue healing effects in multiple animal models but has no published randomized controlled trials in humans for orthopedic indications. The FDA restricted BPC-157 from compounding under Section 503A in 2023, meaning any current use occurs outside regulatory safety frameworks.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 4 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @holistichealthcode's peptide therapy claims need context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@holistichealthcode's peptide therapy claims need context should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@holistichealthcode's peptide therapy claims need context" from hhc+. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is using self-administered injectable BPC-157 sourced from a compounding pharmacy to address a chronic shoulder injury, reporting dose-dependent anxiety at higher units that resolved upon dose reduction.

The reason this review is not generic is the source wording and the canonical claim label "peptides tiktok 7200949051758595371." In this clip, the useful excerpt is: "Good morning you guys." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Multifunctionality and Possible Medical Application of the BPC 157 Peptide (2025), Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing (2019), and Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The FDA restricted BPC-157 from compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act in 2023, citing insufficient safety and clinical evidence.
People who land here are usually trying to understand whether the Peptide social video fact-checks claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is using self-administered injectable BPC-157 sourced from a compounding pharmacy to address a chronic shoulder injury, reporting dose-dependent anxiety at higher units that resolved upon dose reduction.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is using self-administered injectable BPC-157 sourced from a compounding pharmacy to address a chronic shoulder injury, reporting dose-dependent anxiety at higher units that resolved upon dose reduction. BPC-157 has demonstrated tendon and connective tissue healing effects in multiple animal models but has no published randomized controlled trials in humans for orthopedic indications. The FDA restricted BPC-157 from compounding under Section 503A in 2023, meaning any current use occurs outside regulatory safety frameworks.
  • As of mid-2024, zero published randomized controlled trials have tested BPC-157 for orthopedic injury or gut healing in humans. All positive data comes from animal models.
  • The FDA restricted BPC-157 from compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act in 2023, citing insufficient safety and clinical evidence.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • As of mid-2024, zero published randomized controlled trials have tested BPC-157 for orthopedic injury or gut healing in humans. All positive data comes from animal models.
  • The FDA restricted BPC-157 from compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act in 2023, citing insufficient safety and clinical evidence.
  • BPC-157 interacts with dopaminergic and serotonergic systems, making dose-dependent CNS effects including anxiety biologically plausible, though unconfirmed in human trials (Sikiric et al., Current Neuropharmacology, 2020).
  • Pain reduction after three days of BPC-157 is not evidence of structural tissue repair. Soft tissue remodeling operates on a timeline of weeks to months, not days.
  • Compounded peptide preparations lack FDA review for purity, sterility, or accurate concentration, meaning the actual dose delivered by any vial is not guaranteed.
  • The creator's self-correction on dose after two adverse events is a reasonable harm-reduction response, but it does not validate the therapy or make self-injection of unregulated compounds safe.
  • Evidence-backed treatments for chronic shoulder injury include physical therapy, corticosteroid or PRP injections (depending on pathology), and surgical intervention, all supported by human clinical trial data.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @holistichealthcode actually say?

The creator is self-administering injectable BPC-157, purchased through a compounding pharmacy, to treat a chronic shoulder injury and support gut health. After starting at "25 units" and experiencing significant anxiety twice, they dropped to "10 units" on day three and reported no shoulder pain after a Pilates session. They're careful to hedge, noting their shoulder pain "ebbs and flows" and that three days is not enough to call it a cure.

To their credit, they flag compounding variables, they acknowledge they ignored their colleague's dosing advice, and they stop short of claiming BPC-157 definitively fixed anything. That kind of epistemic caution is rare in peptide content on TikTok. Still, the framing of "no shoulder pain already at day three" carries an implicit message even when the words technically disclaim it.

Does the science back this up?

The honest answer is: not in humans, not yet. BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a protein found in gastric juice. The evidence base is almost entirely preclinical.

Animal studies have shown some genuinely interesting results. Sikiric et al. have published extensively in journals like Current Pharmaceutical Design (2018) on BPC-157's effects on tendon and ligament healing in rats, including upregulation of growth hormone receptor expression and angiogenesis at injury sites. A 2021 review in Biomedicines by Chang et al. summarized multiple rodent studies showing accelerated rotator cuff and Achilles tendon repair. These are not nothing. But rats are not people, and the leap from rodent tendon models to human shoulder pathology is a large one that no published clinical trial has bridged. There are no peer-reviewed randomized controlled trials in humans for BPC-157 and orthopedic injury as of mid-2024. The gut healing angle has a similar evidence profile: compelling in animals, unproven in humans.

What did they get wrong (or right)?

The anxiety side effect report is actually consistent with what limited anecdotal and mechanistic literature exists. BPC-157 interacts with dopaminergic and serotonergic systems, and some researchers have hypothesized both anxiolytic and, paradoxically, anxiogenic responses depending on dose and individual neurochemistry (Sikiric et al., Current Neuropharmacology, 2020). Reporting the same symptom twice before adjusting dose is a reasonable self-experiment, even if it is not science.

What is harder to defend is the implicit suggestion that three days of BPC-157 produced a meaningful therapeutic effect on a years-long injury. Soft tissue remodeling takes weeks to months. If the shoulder felt better on day three after one Pilates class, that is almost certainly not structural repair. It could be a training day that happened to go well, a placebo response, or systemic anti-inflammatory activity. The creator hints at this but does not say it clearly enough for a 96,000-view audience.

  • The dose-response anxiety observation: plausible and worth noting.
  • Three-day pain relief as evidence of healing: not supported by anything we know about tissue biology.

What should you actually know?

BPC-157 sits in a regulatory gray zone. It is not FDA-approved for any indication. Compounding pharmacies can prepare it, but compounded drugs are not FDA-reviewed for safety or efficacy the way approved drugs are. The source, sterility, and actual peptide concentration in any compounded vial can vary, and there is no public standard for what "25 units" or "10 units" means across different preparations. That ambiguity matters when you are injecting something.

The FDA placed BPC-157 on its list of substances that cannot be compounded under Section 503A of the Federal Food, Drug, and Cosmetic Act in 2023, citing lack of clinical evidence and safety data. This does not mean the peptide has no future, but it does mean anyone using it right now is doing so without regulatory safety backing.

If you have a chronic shoulder injury, the evidence-backed options include physical therapy, corticosteroid or PRP injections depending on the pathology, and in some cases surgery. Those are not as compelling as a TikTok testimonial, but they have actual human trial data behind them.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

hhc+ · TikTok creator

96.0K views on this video

@holistichealthcode's peptide therapy claims need context

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about as of mid-2024, zero published randomized controlled trials have tested?

As of mid-2024, zero published randomized controlled trials have tested BPC-157 for orthopedic injury or gut healing in humans. All positive data comes from animal models.

What does the video say about the fda restricted bpc-157 from compounding under section 503a of?

The FDA restricted BPC-157 from compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act in 2023, citing insufficient safety and clinical evidence.

What does the video say about bpc-157 interacts with dopaminergic?

BPC-157 interacts with dopaminergic and serotonergic systems, making dose-dependent CNS effects including anxiety biologically plausible, though unconfirmed in human trials (Sikiric et al., Current Neuropharmacology, 2020).

What does the video say about pain reduction after three days of bpc-157?

Pain reduction after three days of BPC-157 is not evidence of structural tissue repair. Soft tissue remodeling operates on a timeline of weeks to months, not days.

What does the video say about compounded peptide preparations lack fda review for purity, sterility,?

Compounded peptide preparations lack FDA review for purity, sterility, or accurate concentration, meaning the actual dose delivered by any vial is not guaranteed.

What does the video say about the creator's self-correction on dose after two adverse events?

The creator's self-correction on dose after two adverse events is a reasonable harm-reduction response, but it does not validate the therapy or make self-injection of unregulated compounds safe.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by hhc+, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.